Medicom Conference Report ESMO 2023最新文献

筛选
英文 中文
Two potential new first-line standards of care in metastatic urothelial cancer 两种潜在的转移性尿路上皮癌一线治疗新标准
Medicom Conference Report ESMO 2023 Pub Date : 2023-12-19 DOI: 10.55788/b4727546
Marten Dooper
{"title":"Two potential new first-line standards of care in metastatic urothelial cancer","authors":"Marten Dooper","doi":"10.55788/b4727546","DOIUrl":"https://doi.org/10.55788/b4727546","url":null,"abstract":"","PeriodicalId":506787,"journal":{"name":"Medicom Conference Report ESMO 2023","volume":"116 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139171607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perioperative durvalumab/FLOT improves pCR in gastric cancer 杜伐单抗/FLOT围手术期可改善胃癌的pCR
Medicom Conference Report ESMO 2023 Pub Date : 2023-12-19 DOI: 10.55788/1ab5484b
Marten Dooper
{"title":"Perioperative durvalumab/FLOT improves pCR in gastric cancer","authors":"Marten Dooper","doi":"10.55788/1ab5484b","DOIUrl":"https://doi.org/10.55788/1ab5484b","url":null,"abstract":"","PeriodicalId":506787,"journal":{"name":"Medicom Conference Report ESMO 2023","volume":"41 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139171645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Darovasertib/crizotinib combination: a potential first-line therapy in metastatic uveal melanoma 达罗伐替尼/克唑替尼联合疗法:转移性葡萄膜黑色素瘤的潜在一线疗法
Medicom Conference Report ESMO 2023 Pub Date : 2023-12-19 DOI: 10.55788/4e12bd5d
Marten Dooper
{"title":"Darovasertib/crizotinib combination: a potential first-line therapy in metastatic uveal melanoma","authors":"Marten Dooper","doi":"10.55788/4e12bd5d","DOIUrl":"https://doi.org/10.55788/4e12bd5d","url":null,"abstract":"","PeriodicalId":506787,"journal":{"name":"Medicom Conference Report ESMO 2023","volume":"29 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139171286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dato-DXd outperforms docetaxel in previously treated patients with metastatic NSCLC 在既往接受过治疗的转移性 NSCLC 患者中,Dato-DXd 的疗效优于多西他赛
Medicom Conference Report ESMO 2023 Pub Date : 2023-12-19 DOI: 10.55788/aee1e2ff
Marten Dooper
{"title":"Dato-DXd outperforms docetaxel in previously treated patients with metastatic NSCLC","authors":"Marten Dooper","doi":"10.55788/aee1e2ff","DOIUrl":"https://doi.org/10.55788/aee1e2ff","url":null,"abstract":"","PeriodicalId":506787,"journal":{"name":"Medicom Conference Report ESMO 2023","volume":"59 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139171802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
No benefit of erdafitinib over pembrolizumab in urothelial cancer second-line therapy 在尿路癌二线治疗中,erdafitinib与pembrolizumab相比没有优势
Medicom Conference Report ESMO 2023 Pub Date : 2023-12-19 DOI: 10.55788/0b543d83
Marten Dooper
{"title":"No benefit of erdafitinib over pembrolizumab in urothelial cancer second-line therapy","authors":"Marten Dooper","doi":"10.55788/0b543d83","DOIUrl":"https://doi.org/10.55788/0b543d83","url":null,"abstract":"","PeriodicalId":506787,"journal":{"name":"Medicom Conference Report ESMO 2023","volume":"69 14","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139172386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lifileucel induces a durable response in heavily pretreated mucosal melanoma Lifileucel 可诱导重度预处理粘膜黑色素瘤产生持久反应
Medicom Conference Report ESMO 2023 Pub Date : 2023-12-19 DOI: 10.55788/8e715344
Marten Dooper
{"title":"Lifileucel induces a durable response in heavily pretreated mucosal melanoma","authors":"Marten Dooper","doi":"10.55788/8e715344","DOIUrl":"https://doi.org/10.55788/8e715344","url":null,"abstract":"","PeriodicalId":506787,"journal":{"name":"Medicom Conference Report ESMO 2023","volume":"46 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139172083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Active surveillance after neoadjuvant chemoradiotherapy in oesophageal cancer 食道癌新辅助化疗后的主动监测
Medicom Conference Report ESMO 2023 Pub Date : 2023-12-19 DOI: 10.55788/dd339a8b
Marten Dooper
{"title":"Active surveillance after neoadjuvant chemoradiotherapy in oesophageal cancer","authors":"Marten Dooper","doi":"10.55788/dd339a8b","DOIUrl":"https://doi.org/10.55788/dd339a8b","url":null,"abstract":"","PeriodicalId":506787,"journal":{"name":"Medicom Conference Report ESMO 2023","volume":"17 21","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139171223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addition of atezolizumab to chemotherapy and maintenance PARP inhibitor has no benefit in ovarian cancer 卵巢癌患者在化疗和维持性PARP抑制剂基础上加用阿替珠单抗无益
Medicom Conference Report ESMO 2023 Pub Date : 2023-12-19 DOI: 10.55788/e258a160
Marten Dooper
{"title":"Addition of atezolizumab to chemotherapy and maintenance PARP inhibitor has no benefit in ovarian cancer","authors":"Marten Dooper","doi":"10.55788/e258a160","DOIUrl":"https://doi.org/10.55788/e258a160","url":null,"abstract":"","PeriodicalId":506787,"journal":{"name":"Medicom Conference Report ESMO 2023","volume":"28 22","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139171242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modified FLOT regime outperforms FOLFOX in advanced/metastatic gastric/gastroesophageal junction adenocarcinoma 在治疗晚期/转移性胃癌/胃食管交界腺癌方面,改良 FLOT 方案优于 FOLFOX 方案
Medicom Conference Report ESMO 2023 Pub Date : 2023-12-19 DOI: 10.55788/97de742b
Marten Dooper
{"title":"Modified FLOT regime outperforms FOLFOX in advanced/metastatic gastric/gastroesophageal junction adenocarcinoma","authors":"Marten Dooper","doi":"10.55788/97de742b","DOIUrl":"https://doi.org/10.55788/97de742b","url":null,"abstract":"","PeriodicalId":506787,"journal":{"name":"Medicom Conference Report ESMO 2023","volume":"42 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139172300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Short-induction chemotherapy improves survival in advanced cervical cancer 短期化疗可提高晚期宫颈癌患者的生存率
Medicom Conference Report ESMO 2023 Pub Date : 2023-12-19 DOI: 10.55788/c407f4e9
Marten Dooper
{"title":"Short-induction chemotherapy improves survival in advanced cervical cancer","authors":"Marten Dooper","doi":"10.55788/c407f4e9","DOIUrl":"https://doi.org/10.55788/c407f4e9","url":null,"abstract":"","PeriodicalId":506787,"journal":{"name":"Medicom Conference Report ESMO 2023","volume":"419 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139171703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书